Oxidative stress in phenylketonuric patients

Molecular Genetics and Metabolism

Volumn 104, Issue SUPPL., 2011, Pages

  Vargas, C R ^a,b   Wajner, M ^a,b   Sitta, A ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Antioxidants; Oxidative stress; Phenylketonuria

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

ADJUVANT THERAPY; ARTICLE; DIET RESTRICTION; HUMAN; OXIDATIVE STRESS; PHENYLKETONURIA; PRIORITY JOURNAL;

ANTIOXIDANTS; BIOLOGICAL MARKERS; HUMANS; OXIDATIVE STRESS; PHENYLKETONURIAS;

EID: 82755193700     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.07.010     Document Type: Article

References (25)

1. Scriver C.R., Kaufman S. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. The Metabolic and Molecular Bases of Inherited Disease 2001, 1667-1724. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
2. Hoeksma M., Reijngoud D.J., Pruim J., de Valk H.W., Paans A.M., van Spronsen F.J. Phenylketonuria: high plasma phenylalanine decreases cerebral protein synthesis. Mol. Genet. Metab. 2009, 96:177-182.
3. Tam S.Y., Roth R.H. Mesoprefrontal dopaminergic neurons: can tyrosine availability influence their functions?. Biochem. Pharmacol. 1997, 53:441-453.
4. Kaufman S. An evaluation of the possible neurotoxicity of metabolites of phenylalanine. J. Pediatr. 1989, 114:895-900.
5. Sierra C., Vilaseca M.A., Moyano D., Brandi N., Campistol J., Lambruschini N., Cambra F.J., Deulofeu R., Mira A. Antioxidant status in hyperphenylalaninemia. Clin. Chim. Acta 1998, 276:1-9.
6. Artuch R., Colome C., Sierra C., Brandi N., Lambruschini N., Campistol J., Ugarte D., Vilaseca M.A. A longitudinal study of antioxidant status in phenylketonuric patients. Clin. Biochem. 2004, 3:198-203.
7. Sanayama Y., Nagasaka H., Takayanagi M., Ohura T., Sakamoto O., Ito T., Ishige-Wada M., Usui H., Yoshino M., Ohtake A., Yorifuji T., Tsukahara H., Hirayama S., Miida T., Fukui M., Okano Y. Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. Mol. Genet. Metab. 2011, 103:220-225.
8. Schulpis K.H., Papastamataki M., Stamou H., Papassotiriou I., Margeli A. The effect of diet on total antioxidant status, ceruloplasmin, transferrin and ferritin serum levels in phenylketonuric children. Acta Paediatr. 2010, 99:1565-1570.
9. Moraes T.B., Zanin F., da Rosa A., de Oliveira A., Coelho J., Petrillo F., Wajner M., Dutra-Filho C.S. Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain. J. Neurol. Sci. 2010, 15:89-95.
10. Fernandes C.G., Leipnitz G., Seminotti B., Amaral A.U., Zanatta A., Vargas C.R., Dutra Filho C.S., Wajner M. Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats. Cell. Mol. Neurobiol. 2009, 30:317-326.
11. Halliwell B., Gutteridge J.M.C. Oxidative stress: adaptation, damage, repair and death. Free Radicals in Biology and Medicine 2007, 246-350. Oxford University Press, Oxford. B. Halliwell, J.M.C. Gutteridge (Eds.).
12. Colome C., Artuch R., Vilaseca M.A., Sierra C., Brandi N., Lambruschini N., Cambra F.J., Campistol J. Lipophilic antioxidants in patients with phenylketonuria. Am. J. Clin. Nutr. 2003, 77:185-188.
13. Gassió R., Artuch R., Vilaseca M.A., Fusté E., Colome R., Campistol J. Cognitive functions and the antioxidant system in phenylketonuric patients. Neuropsych. 2008, 22:426-431.
14. Sitta A., Barschak A.G., Deon M., De Mari J.F., Barden A.B., Vanzin C., Biancini G.B., Schwartz I.V.D., Wajner M., Vargas C.R. l-Carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cell Mol. Neurobiol. 2009, 29:211-218.
15. Sitta A., Barschak A.G., Deon M., Barden A.T., Biancini G.B., Vargas P.R., de Souza C.F., Netto C., Wajner M., Vargas C.R. Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients. Int. J. Dev. Neurosci. 2009, 27:243-247.
16. Sitta A., Barschak A.G., Deon M., Terroso T., Pires R., Giugliani R., Dutra-Filho C.S., Wajner M., Vargas C.R. Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab. Brain Dis. 2006, 21:287-296.
17. Sirtori L.R., Dutra-Filho C.S., Fitarelli D., Sitta A., Haeser A., Barschak A.G., Wajner M., Coelho D.M., Llesuy S., Belló-Klein A., Giugliani R., Deon M., Vargas C.R. Oxidative stress in patients with phenylketonuria. Biochim. Biophys. Acta 2005, 1740:68-73.
18. Schulpis K.H., Tsakiris S., Traeger-Synodinos J., Papassotiriou I. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Clin. Biochem. 2005, 38:239-242.
19. Sitta A., Manfredini V., Biasi L., Treméa R., Schwartz I.V.D., Wajner M., Vargas C.R. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients. Mutat. Res. 2009, 679:13-16.
20. Van Bakel M.M., Printzen G., Wermuth B., Wiesmann U.N. Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am. J. Clin. Nutr. 2000, 72:976-981.
21. Wilke B.C., Vidailhet M., Favier A., Guillemin C., Ducros V., Arnaud J., Richard M.J. Selenium, glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementation. Clin. Chim. Acta 1992, 207:137-142.
22. Artuch R., Vilaseca M.A., Moreno J., Lambruschini N., Cambra F.J., Campistol J. Decreased serum ubiquinone-10 concentrations in phenylketonuria. Am. J. Clin. Nutr. 1999, 70:892-895.
23. Gülçin I. Antioxidant and antiradical activities of l-carnitine. Life Sci. 2006, 78:803-811.
24. Schulpis K.H., Nounopoulos C., Scarpalezou A., Bouloukos A., Missiou-Tsagarakis S. Serum carnitine level in phenylketonuric children under dietary control in Greece. Acta Paediatr. Scand. 1990, 79:930-934.
25. Sitta A., Vanzin C.S., Biancini G.B., Manfredini V., de Oliveira A.B., Wayhs C.A.Y., Ribas G.O., Giugliani L., Schwartz I.V.D., Bohrer D., Garcia S.C., Wajner M., Vargas C.R. Evidence that l-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients. Cell. Mol. Neurobiol. 2011, 31:429-436.